<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7233653\results\search\disease\results.xml">
  <result pre="Influenza virological surveillance is essential for monitoring the evolution of" exact="influenza" post="viruses (IVs) as well as for annual updating of"/>
  <result pre="Genetic characterization was performed for a spatial-temporal representative number of" exact="influenza" post="laboratory-confirmed specimens. Results: Influenza-positive samples per season ranged between"/>
  <result pre="seasons a complete or nearly complete mismatch between the predominant" exact="influenza" post="B lineage of IVs type B circulating and vaccine"/>
  <result pre="IVs circulation, to improve the most appropriate vaccination strategies. (www.actabiomedica.it)" exact="influenza" post="virus virological surveillance antigenic characterisation B lineage vaccine virus"/>
  <result pre="antigenic characterisation B lineage vaccine virus strain mismatch Introduction Seasonal" exact="influenza" post="is an acute, highly contagious viral respiratory infection of"/>
  <result pre="(1). Influenza epidemiology mainly depends on the particular characteristics of" exact="influenza" post="viruses (IVs), able to spread all over the world"/>
  <result pre="every year with different intensity and trend. The impact of" exact="influenza" post="also varies according to different age groups, in terms"/>
  <result pre="antigenically distinct, occurred starting from 1983 (11). Within this context," exact="influenza" post="epidemiological and virological surveillance plays an essential role and"/>
  <result pre="Centre for Disease Prevention and Control (ECDC) (13). The national" exact="influenza" post="surveillance systems, together with the analysis of epidemiological features,"/>
  <result pre="manner (14). In Italy, these activities are carried out by" exact="influenza" post="surveillance system, named InfluNet, coordinated by the National Influenza"/>
  <result pre="a clinical presentation of influenza-like illness (ILI) (15-17). The regional" exact="influenza" post="Laboratories perform isolations and antigenic characterizations of IVs during"/>
  <result pre="the target population, is the real reduction of effectiveness of" exact="influenza" post="vaccine on field. (19,25-28). The aim of this paper"/>
  <result pre="by analysis of virological surveillance data, performed by the regional" exact="influenza" post="reference Laboratory of Parma (29-31). Methods Respiratory specimens from"/>
  <result pre="in compliance with institutional guidelines (33-34). A representative number of" exact="influenza" post="laboratory-confirmed specimens and viral isolates, were sent to the"/>
  <result pre="analysis. Results During the study period, the reference Laboratory for" exact="influenza" post="virological surveillance of Emilia-Romagna, analysed 7882 nasal or throat"/>
  <result pre="the surveyed area, epidemiological trends observed in the first six" exact="influenza" post="seasons were quite similar and analogous to that of"/>
  <result pre="2017-2018 seasons, a clear shift was observed in epidemiological trend:" exact="influenza" post="activity started about four weeks in advance, with a"/>
  <result pre="from 2010-2011 to 2017-2018 season Table 2. Number (%) of" exact="influenza" post="virus positive by age groups and influenza season Flu"/>
  <result pre="Number (%) of influenza virus positive by age groups and" exact="influenza" post="season Flu season Age group (years) Results Flu negative"/>
  <result pre="398 (67.3%) 193 (32.7%) 591 Figure 2. Distribution (%) of" exact="influenza" post="positive samples by age group and by season (from"/>
  <result pre="match with seasonal vaccine strains (Table 3). Table 3. Circulating" exact="influenza" post="viruses in Emilia-Romagna vs vaccine strains from 2010-2011 to"/>
  <result pre="mismatch is highlighted) Season Trivalent vaccine composition (vaccine strains) Circulating" exact="influenza" post="viruses A/H1N1pdm09 A/H3N2 B (lineage) A/H1N1pdm09 A/H3N2 B (lineage)"/>
  <result pre="seasons a complete or nearly complete mismatch between the predominant" exact="influenza" post="B lineage and vaccine B lineage occurred. In 2015-2016"/>
  <result pre="this study we highlight that in none of the epidemic" exact="influenza" post="season full match was achieved. Probably the Health Technology"/>
  <result pre="fill the information gap in the setting of the new" exact="influenza" post="vaccine (48-55). This study also confirms the importance of"/>
  <result pre="(last accessed on 12 June 2019) 2PetrovaVNRussellCThe evolution of seasonal" exact="influenza" post="virusesNature Reviews Microbiology201816476029081496 3HortonKCDuegerELKandeeAAbdallatMEl-KholyAAl-AwaidySet al.Viral etiology, seasonality and severity"/>
  <result pre="the Eastern Mediterranean Region, 2007-2014PLoS ONE2017127e018095428704440 4PirallaALunghiGRuggieroLGirelloABianchiniSRovidaFet al.Molecular epidemiology of" exact="influenza" post="B virus among hospitalized pediatric patients in Northern Italy"/>
  <result pre="ONE20171210e018589329049310 5MertzDGeraciJWinkupJGessnerBDOrtizJRLoebMPregnancy as a risk factor for severe outcomes from" exact="influenza" post="virus infection: A systematic review and meta-analysis of observational"/>
  <result pre="observational studiesVaccine20173552152828024955 6SegaloffHEPetrieJGMaloshREChengCKMcSpaddenEJFerdinandsJMet al.Severe morbidity among hospitalized adults with acute" exact="influenza" post="and other respiratory infections; 2014–15 and 2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe"/>
  <result pre="2015–16Epidemiol Infect2018146111350135829880077 7MaloshREMartinETOrtizJRMontoASThe risk of lower respiratory tract infection following" exact="influenza" post="virus infection: A systematic and narrative reviewVaccine201836114114729157959 8IulianoADRoguskiKMChangHHMuscatelloDJPalekarRTempiaSet al.Estimates"/>
  <result pre="Stockholm, 2019Euro Surveill201924231900348 10NeumannGNodaTKawaokaYEmergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature20194597249931959 11RotaPAWallisTRHarmonMWRotaJSKendalAPNeromeKCocirculation of two distinct evolutionary lineages of influenza"/>
  <result pre="H1N1 influenza virusNature20194597249931959 11RotaPAWallisTRHarmonMWRotaJSKendalAPNeromeKCocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983Virology1990175159682309452 12World Health Organization Global"/>
  <result pre="European Centre for Disease Prevention and Control (ECDC)National and global" exact="influenza" post="surveillance system and reportAvailable from: https://ecdc.europa.eu/en/seasonal-influenza/surveillance-and-disease-data/national-regional-global-reports (last accessed on"/>
  <result pre="from: http://www.salute.gov.it/portale/influenza/homeInfluenza.jsp (last accessed on 12 June 2019) 18BelongiaEASimpsonMDKingJPSundaramMEKelleyNSOsterholmMTet al.Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
  <result pre="design studiesLancet Infect Dis2016894295127061888 19EichnerMSchwehmMEichner, GerlierLDirect and indirect effects of" exact="influenza" post="vaccinationBMC Infectious Diseases201717130828441935 20KisslingEValencianoMLarrauriAOrosziBCohenJMNunesBet al.Low and decreasing vaccine effectiveness"/>
  <result pre="vaccinationBMC Infectious Diseases201717130828441935 20KisslingEValencianoMLarrauriAOrosziBCohenJMNunesBet al.Low and decreasing vaccine effectiveness against" exact="influenza" post="A(H3) in 2011/12 among vaccination target groups in Europe:"/>
  <result pre="the I-MOVE multicentre case–control studyEuro Surveill20131852039023399425 21ValencianoMKisslingETeamIEarly estimates of seasonal" exact="influenza" post="vaccine effectiveness in Europe: results from the I-MOVE multicentre"/>
  <result pre="multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against" exact="influenza" post="A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among"/>
  <result pre="effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched" exact="influenza" post="B among childrenInfluenza Other Respir Viruses201812442343729125681 24KisslingERoseAEmborgHDet al.European IVE"/>
  <result pre="childrenInfluenza Other Respir Viruses201812442343729125681 24KisslingERoseAEmborgHDet al.European IVE Group. Interim 2018/19" exact="influenza" post="vaccine effectiveness: six European studies, October 2018 to January"/>
  <result pre="1994-1997Annali di igiene: medicina preventiva e di comunità2000121713 30TanziMLAffanniPRizzieroSVeronesiLColucciMESurveillance of" exact="influenza" post="in a city of north Italy from 1997 to"/>
  <result pre="Medicine and Hygiene20044535156 31ChiapponiCEbranatiEParianiEFacciniSLuppiABaioniLet al.Genetic analysis of human and swine" exact="influenza" post="A viruses isolated in Northern Italy during 2010–2015Zoonoses Public"/>
  <result pre="34World Health Organization - WHO information for molecular diagnosis of" exact="influenza" post="virus – Publication date: July 2017Available from: http://www.who.int/influenza/gisrs_laboratory/molecular_diagnosis/en/ (last"/>
  <result pre="on 12 June 2019) 35collab: WHORecommendations on the composition of" exact="influenza" post="virus vaccinesAvailable from: https://www.who.int/influenza/vaccines/virus/recommendations/2018_19_north/en/ (last accessed on 12 June"/>
  <result pre="accessed on 12 June 2019) 36ParianiEAmendolaAPiattiAAnselmiGRanghiroABubbaLet al.Ten years (2004-2014) of" exact="influenza" post="surveillance in Northern ItalyHum Vaccin Immunother201511119820525483536 37ParianiEAmendolaAEbranatiERanghieroALaiAAnselmiGet al.Genetic drift"/>
  <result pre="influenza surveillance in Northern ItalyHum Vaccin Immunother201511119820525483536 37ParianiEAmendolaAEbranatiERanghieroALaiAAnselmiGet al.Genetic drift" exact="influenza" post="A(H3N2) virus hemagglutinin (HA) variants originated during the last"/>
  <result pre="season in Northern ItalyInfect Genet Evol20131325226023174527 38OrsiAColomba GMEPojeroFCalamusaGAlicinoCTrucchiCet al.Trends of" exact="influenza" post="B during the 2010–2016 seasons in 2 regions of"/>
  <result pre="and south Italy: The impact of the vaccine mismatch on" exact="influenza" post="immunisation strategyHum Vaccin Immunother201814352353128708953 39TramutoFOrsiAMaidaCMCostantinoCTrucchiCAlicinoCet al.The Molecular Epidemiology and"/>
  <result pre="February and March 2012Euro Surveill20121714 41KelvinDJFarooquiAExtremely low vaccine effectiveness against" exact="influenza" post="H3N2 in the elderly during the 2012/2013 flu seasonJ"/>
  <result pre="2017Euro Surveill201722143050628424146 43RondyMGherasimACasadoILaunayORizzoCPitigoiDet al.Low 2016/17 season vaccine effectiveness against hospitalised" exact="influenza" post="A(H3N2) among elderly: awareness warranted for 2017/18 seasonEuro Surveill2017224100645"/>
  <result pre="seasonEuro Surveill2017224100645 44CainiSSpreeuwenbergPKusznierzGFRudiJMOwenRPenningtonKet al.Global Influenza B Study group. Distribution of" exact="influenza" post="virus types by age using case-based global surveillance data"/>
  <result pre="twenty-nine countries, 1999-2014BMC Infect Dis201818126929884140 45SullivanSGPriceOHReganAKBurden, effectiveness and safety of" exact="influenza" post="vaccines in elderly, paediatric and pregnant populationsTherapeutic Advances in"/>
  <result pre="Advances in Vaccines and Immunotherapy20197116 46AngLWCuiLMakTMNgYLeoYSLeeVJMet al.Differential age-specific distribution of" exact="influenza" post="virus types and subtypes in tropical Singapore, 2011 to"/>
  <result pre="Singapore, 2011 to 2017J Med Virol20199181415142230927452 47LytrasTPantavouKMouratidouETsiodrasSMortality attributable to seasonal" exact="influenza" post="in Greece, 2013 to 2017: variation by type/subtype and"/>
  <result pre="the Health Technology Assessment approachVaccine200826131609161018289744 49SimonCKudahlUJSunJOlsenLRZhangGLReinherzELBrusicVFluKB: a knowledge-based system for" exact="influenza" post="vaccine target discovery and analysis of the immunological properties"/>
  <result pre="vaccine target discovery and analysis of the immunological properties of" exact="influenza" post="virusesJ Immunol Res201538097526504853 50RenXLiYLiuXShenXGaoWLiJComputational identification of antigenicity-associated sites in"/>
  <result pre="of antigenicity-associated sites in the hemagglutinin protein of A/H1N1 seasonal" exact="influenza" post="virusPLoS One20151050126742 51HswenYBrownsteinJSLiuJHawkinsJBUse of a Digital Health Application for"/>
  <result pre="influenza virusPLoS One20151050126742 51HswenYBrownsteinJSLiuJHawkinsJBUse of a Digital Health Application for" exact="influenza" post="surveillance in ChinaAm J Public Health201710771130113628520492 52DePasseJVNowalkMPSmithKJRaviottaJMShimEZimmermanRKet al.Does cost-effectiveness"/>
  <result pre="surveillance in ChinaAm J Public Health201710771130113628520492 52DePasseJVNowalkMPSmithKJRaviottaJMShimEZimmermanRKet al.Does cost-effectiveness of" exact="influenza" post="vaccine choice vary across the U.S.? An agent-based modeling"/>
 </snippets>
</snippetsTree>
